This system was used for treatment.No kit lot number provided; therefore, batch record review could not be conducted.The uvadex lot number was not provided as it was not administered.However, a review of all uvadex lots manufactured since january 2013 was performed.No trends or nonconformances related to the complaint were noted.Trends were reviewed and no trends were detected for complaint category clot observed.This assessment is based on information available at the time of the investigation.No product was returned by the customer for investigation; therefore, it could not be determined if this specific product met specification.Per the complaint description the most likely cause for the event was the operator swapping the a/c and saline bags, hence causing the clot to form.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).Device not returned for investigation.
|
On a conference call, a customer's staff member reported a concern about the operator improperly spiking the a/c and saline bags, which as expected was an issue once the treatment initiated.Customer reported that, at 800 ml of whole blood processed (wbp), they realized that the saline and a/c line were swapped.Customer reported the blood in the return bag was clotted and could not be returned to the patient.The customer reported the patient was transfused 1 unit of packed red blood cells.Customer reported that they did not report the complaint earlier because it was related to operator error.This event occurred on (b)(6) 2015.Cse thanked the customer for the information and reminded them the hotline will help support the customer all treatments.Patient was reported to be stable.
|